248 related articles for article (PubMed ID: 18664560)
1. Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up.
Diel IJ; Jaschke A; Solomayer EF; Gollan C; Bastert G; Sohn C; Schuetz F
Ann Oncol; 2008 Dec; 19(12):2007-11. PubMed ID: 18664560
[TBL] [Abstract][Full Text] [Related]
2. Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].
Powles T; Paterson A; McCloskey E; Schein P; Scheffler B; Tidy A; Ashley S; Smith I; Ottestad L; Kanis J
Breast Cancer Res; 2006; 8(2):R13. PubMed ID: 16542503
[TBL] [Abstract][Full Text] [Related]
3. Oral sodium clodronate for nonmetastatic prostate cancer--results of a randomized double-blind placebo-controlled trial: Medical Research Council PR04 (ISRCTN61384873).
Mason MD; Sydes MR; Glaholm J; Langley RE; Huddart RA; Sokal M; Stott M; Robinson AC; James ND; Parmar MK; Dearnaley DP;
J Natl Cancer Inst; 2007 May; 99(10):765-76. PubMed ID: 17505072
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials.
Dearnaley DP; Mason MD; Parmar MK; Sanders K; Sydes MR
Lancet Oncol; 2009 Sep; 10(9):872-6. PubMed ID: 19674936
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.
Saarto T; Blomqvist C; Virkkunen P; Elomaa I
J Clin Oncol; 2001 Jan; 19(1):10-7. PubMed ID: 11134190
[TBL] [Abstract][Full Text] [Related]
6. Reduction in new metastases in breast cancer with adjuvant clodronate treatment.
Diel IJ; Solomayer EF; Costa SD; Gollan C; Goerner R; Wallwiener D; Kaufmann M; Bastert G
N Engl J Med; 1998 Aug; 339(6):357-63. PubMed ID: 9691101
[TBL] [Abstract][Full Text] [Related]
7.
Paterson AHG; Lucas PC; Anderson SJ; Mamounas EP; Brufsky A; Baez-Diaz L; King KM; Lad T; Robidoux A; Finnigan M; Sampayo M; Tercero JC; Mairet JJ; Wolff AC; Fehrenbacher L; Wolmark N; Gomis RR
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377934
[TBL] [Abstract][Full Text] [Related]
8. Oral adjuvant clodronate therapy could improve overall survival in early breast cancer: results from an updated systematic review and meta-analysis.
Zhu J; Zheng Y; Zhou Z
Eur J Cancer; 2013 Jun; 49(9):2086-92. PubMed ID: 23452992
[TBL] [Abstract][Full Text] [Related]
9. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.
Gralow JR; Barlow WE; Paterson AHG; M'iao JL; Lew DL; Stopeck AT; Hayes DF; Hershman DL; Schubert MM; Clemons M; Van Poznak CH; Dees EC; Ingle JN; Falkson CI; Elias AD; Messino MJ; Margolis JH; Dakhil SR; Chew HK; Dammann KZ; Abrams JS; Livingston RB; Hortobagyi GN
J Natl Cancer Inst; 2020 Jul; 112(7):698-707. PubMed ID: 31693129
[TBL] [Abstract][Full Text] [Related]
10. Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
Leppä S; Saarto T; Vehmanen L; Blomqvist C; Elomaa I
Breast Cancer Res Treat; 2005 Mar; 90(2):117-25. PubMed ID: 15803358
[TBL] [Abstract][Full Text] [Related]
11. Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
Saarto T; Vehmanen L; Blomqvist C; Elomaa I
J Clin Oncol; 2008 Sep; 26(26):4289-95. PubMed ID: 18779616
[TBL] [Abstract][Full Text] [Related]
12. Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.
Paterson AH; Anderson SJ; Lembersky BC; Fehrenbacher L; Falkson CI; King KM; Weir LM; Brufsky AM; Dakhil S; Lad T; Baez-Diaz L; Gralow JR; Robidoux A; Perez EA; Zheng P; Geyer CE; Swain SM; Costantino JP; Mamounas EP; Wolmark N
Lancet Oncol; 2012 Jul; 13(7):734-42. PubMed ID: 22704583
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of clodronate and breast cancer survival.
Ha TC; Li H
Br J Cancer; 2007 Jun; 96(12):1796-801. PubMed ID: 17325699
[TBL] [Abstract][Full Text] [Related]
14. Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.
Saarto T; Vehmanen L; Virkkunen P; Blomqvist C
Acta Oncol; 2004; 43(7):650-6. PubMed ID: 15545185
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer.
McCloskey E; Paterson A; Kanis J; Tähtelä R; Powles T
Eur J Cancer; 2010 Feb; 46(3):558-65. PubMed ID: 20031392
[TBL] [Abstract][Full Text] [Related]
16. Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer.
Powles T; Paterson S; Kanis JA; McCloskey E; Ashley S; Tidy A; Rosenqvist K; Smith I; Ottestad L; Legault S; Pajunen M; Nevantaus A; Männistö E; Suovuori A; Atula S; Nevalainen J; Pylkkänen L
J Clin Oncol; 2002 Aug; 20(15):3219-24. PubMed ID: 12149294
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
18. Extended safety profile of oral clodronate after long-term use in primary breast cancer patients.
Atula S; Powles T; Paterson A; McCloskey E; Nevalainen J; Kanis J
Drug Saf; 2003; 26(9):661-71. PubMed ID: 12814333
[TBL] [Abstract][Full Text] [Related]
19. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
J Clin Oncol; 1997 Apr; 15(4):1341-7. PubMed ID: 9193325
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
